Home NDC 10122-180 Lamzede
Product NDC 10122-180
11-digit product format 101220180
Labeler code 10122
Product ID 10122-180_27cf090b-196e-4330-8184-c72d9bb90660
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Velmanase alfa-tycv
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Chiesi USA, Inc.
Application BLA761278
Marketing category BLA
Marketing start 2023-03-01
Substance VELMANASE ALFA-TYCV
Active strength 10 mg/1
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Lamzede
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength VELMANASE ALFA-TYCV 10 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination M91TG242P2 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2630729 Internal RxNorm lookup 2630734 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 10122-180-02 Lamzede 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 1 10122-180-05 Lamzede 5 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 5 1 10122-180-10 Lamzede 10 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 10 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 10122-180 LAMZEDE (VELMANASE ALFA-TYCV) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CHIESI USA, INC.] 1 Current NDC, 3 package rows 20230301_36d50a08-60bd-40eb-807c-778d69bf2d2e.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Lamzede VELMANASE ALFA-TYCV Chiesi USA, Inc. 36d50a08-60bd-40eb-807c-778d69bf2d2e 2023-02-21 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761278 ndc (product): 10122-180
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761278 Lamzede velmanase alfa-tycv 351(a) Rx 2026-08-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 10122-180-02 10122018002 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-02) 2023-03-01 No No Current 10122-180-05 10122018005 5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-05) 2023-03-01 No No Current 10122-180-10 10122018010 10 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (10122-180-10) 2023-03-01 No No Current